442 
ing such agents that are an emerging infectious 
disease’’ after ‘‘become a pandemic’’; and 
(B) in paragraph (2)(A), by striking 
‘‘$250,000,000 for each of fiscal years 2019 
through 2023’’ and inserting ‘‘$335,000,000 
for each of fiscal years 2025 and 2026, to re-
main available through December 31, 2026’’. 
SEC. 622. NATIONAL HEALTH SECURITY STRATEGY. 
Section 2802 of the Public Health Service Act (42 
U.S.C. 300hh–1) is amended— 
(1) in subsection (a)(3)— 
(A) by striking ‘‘In 2022, the’’ and insert-
ing ‘‘The’’; and 
(B) by inserting ‘‘, maintaining, and sus-
taining’’ after ‘‘establishing’’; and 
(2) in subsection (b)— 
(A) in paragraph (2)— 
(i) in subparagraph (A), by inserting 
‘‘that support interagency coordination and 
availability of information, as appropriate’’ 
before the period; and 
(ii) in subparagraph (B), by inserting 
‘‘rapid testing,’’ after ‘‘and supplies,’’; 
(B) in paragraph (3)— 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00442
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
443 
(i) in the matter preceding subpara-
graph (A), by inserting ‘‘and blood banks’’ 
after ‘‘dental health facilities’’; 
(ii) in subparagraph (C), by inserting 
‘‘and current capacity of facilities within 
such systems, as applicable’’ before the pe-
riod; and 
(iii) in subparagraph (D), by inserting 
‘‘and other medical products and medical 
supplies consistent with the activities car-
ried out under section 2811(b)(4)(J)’’ be-
fore the period; 
(C) in paragraph (5), by inserting ‘‘appli-
cable federally funded activities and’’ after ‘‘(in-
cluding’’; 
(D) in paragraph (8)— 
(i) in subparagraph (A), by inserting 
‘‘public health and medical’’ before ‘‘activi-
ties’’; and 
(ii) in subparagraph (B), by striking 
‘‘familiarity with’’ and inserting ‘‘under-
standing of, and coordination between,’’; 
(E) by redesignating paragraphs (9) and 
(10) as paragraphs (10) and (12), respectively; 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00443
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
444 
(F) by inserting after paragraph (8) the 
following: 
‘‘(9) OTHER
SETTINGS.—Supporting Federal, 
State, local, and Tribal coordination and planning 
with respect to facilities in which there is an in-
creased risk of infectious disease outbreaks, includ-
ing such facilities that address the needs of at-risk 
individuals, in the event of a public health emer-
gency declared under section 319.’’; 
(G) by inserting after subparagraph (10), 
as so redesignated, the following: 
‘‘(11) OTHER
HAZARDS.—Assessing current 
and potential health security threats from natural 
disasters with respect to public health and medical 
preparedness and response.’’; 
(H) by inserting after paragraph (12), as 
so redesignated, the following: 
‘‘(13) CYBERSECURITY RESILIENCY OF HEALTH 
CARE SYSTEMS.—Consistent with the requirements 
of section 2218 of the Homeland Security Act of 
2002, strengthening the ability of States, local com-
munities, and Tribal communities to prepare for, re-
spond to, and be resilient against cybersecurity 
vulnerabilities or cybersecurity attacks that affect 
public health and health information technology, and 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00444
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
445 
encouraging health care facilities to use recognized 
security practices meeting or exceeding the ap-
proaches established under section 405(d) of the Cy-
bersecurity Act of 2015.’’; and 
(I) by striking ‘‘tribal’’ each place it ap-
pears and inserting ‘‘Tribal’’. 
SEC. 623. IMPROVING DEVELOPMENT AND DISTRIBUTION 
OF DIAGNOSTIC TESTS. 
Section 319B of the Public Health Service Act (42 
U.S.C. 247d–2) is amended to read as follows: 
‘‘SEC. 319B. IMPROVING DEVELOPMENT AND DISTRIBU-
TION OF DIAGNOSTIC TESTS. 
‘‘(a) DIAGNOSTIC TESTING PREPAREDNESS PLAN.— 
The Secretary shall develop, make publicly available, not 
later than 1 year after the date of enactment of the Pan-
demic and All-Hazards Preparedness and Response Act, 
and update not less frequently than every 3 years there-
after, a plan for the rapid development, validation, author-
ization, manufacture, procurement, and distribution of di-
agnostic tests, and for rapid scaling of testing capacity, 
in response to chemical, biological, radiological, or nuclear 
threats, including emerging infectious diseases, for which 
a public health emergency is declared under section 319, 
or that has significant potential to cause such a public 
health emergency. 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00445
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
446 
‘‘(b) PURPOSES.—The purpose of the plan under sub-
section (a) shall be to— 
‘‘(1) facilitate the development and utilization 
of diagnostic tests; 
‘‘(2) describe the processes for the rapid devel-
opment, validation, authorization, manufacture, pro-
curement, and distribution of diagnostic tests, and 
for rapid scaling of testing capacity; and 
‘‘(3) facilitate coordination and collaboration 
among public and private entities to improve the 
rapid development and utilization of diagnostic test-
ing during a public health emergency. 
‘‘(c) CONSIDERATIONS.—The plan under subsection 
(a) shall take into consideration— 
‘‘(1) domestic capacity, including any such ca-
pacity established through partnerships with public 
and private entities pursuant to subsection (e), to 
support the development, validation, manufacture, 
procurement, and distribution of tests, and the rapid 
scaling of testing capacity; 
‘‘(2) novel technologies and platforms that— 
‘‘(A) may be used to improve testing capa-
bilities, including— 
‘‘(i) 
high-throughput 
laboratory 
diagnostics; 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00446
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
447 
‘‘(ii) point-of-care diagnostics; and 
‘‘(iii) rapid at-home diagnostics; 
‘‘(B) improve the accessibility of diagnostic 
tests; and 
‘‘(C) facilitate the development and manu-
facture of diagnostic tests; 
‘‘(3) medical supply needs related to testing, in-
cluding diagnostic testing, equipment, supplies, and 
component parts, and any potential vulnerabilities 
related to the availability of such medical supplies 
and related planning needs, consistent with section 
2811(b)(4)(J); 
‘‘(4) strategies for the rapid and efficient dis-
tribution of tests locally, regionally, or nationwide 
and appropriate scaling of laboratory testing capac-
ity; and 
‘‘(5) assessment of such strategies through 
drills and operational exercises carried out under 
section 2811(b)(4)(G), as appropriate. 
‘‘(d) COORDINATION.—To inform the development 
and update of the plan under subsection (a), and in car-
rying out activities to implement such plan, the Secretary 
shall coordinate with industry, such as device manufactur-
ers, clinical and reference laboratories, and medical prod-
uct distributors, States, local governmental entities, In-
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00447
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
448 
dian Tribes and Tribal organizations, and other relevant 
public and private entities. 
‘‘(e) CAPACITY BUILDING.—The Secretary may con-
tract with public and private entities, as appropriate, to 
increase domestic capacity in the rapid development, vali-
dation, authorization, manufacture, procurement, and dis-
tribution of diagnostic tests, as appropriate, to State, 
local, and Tribal health departments and other appro-
priate entities for immediate public health response activi-
ties to address an infectious disease with respect to which 
a public health emergency is declared under section 319, 
or that has significant potential to cause such a public 
health emergency.’’. 
SEC. 624. COMBATING ANTIMICROBIAL RESISTANCE. 
(a) IN GENERAL.—Section 319E of the Public 
Health Service Act (42 U.S.C. 247d–5) is amended— 
(1) in subsection (a)— 
(A) in paragraph (1), by inserting ‘‘and ac-
tivities’’ after ‘‘Federal programs’’; 
(B) in paragraph (2)— 
(i) by striking ‘‘public health constitu-
encies, manufacturers, veterinary and med-
ical professional societies and others’’ and 
inserting ‘‘the Advisory Council described 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00448
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
449 
in subsection (b) and relevant public and 
private entities’’; and 
(ii) by inserting ‘‘, pursuant to para-
graph (4),’’ after ‘‘comprehensive plan’’; 
(C) by amending paragraph (3) to read as 
follows: 
‘‘(3) AGENDA.—The task force described in 
paragraph (1) shall consider factors the Secretary 
considers appropriate, including factors to— 
‘‘(A) slow the emergence of resistant bac-
teria and fungi and prevent the spread of re-
sistant infections; 
‘‘(B) strengthen activities to combat resist-
ance with respect to zoonotic diseases; 
‘‘(C) advance development and use of rapid 
and innovative capabilities, including diagnostic 
tests, for identification and characterization of 
resistant bacteria and fungi; 
‘‘(D) accelerate basic and applied research 
and 
development 
for 
new 
antibiotics, 
antifungals, and other related therapeutics and 
vaccines; and 
‘‘(E) support international collaboration 
and capacities for antimicrobial-resistance pre-
vention, detection, and control.’’; 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00449
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
450 
(D) by redesignating paragraph (4) as 
paragraph (5); and 
(E) by inserting after paragraph (3) the 
following: 
‘‘(4) ACTION PLAN.—Not later than October 1, 
2026, and every 5 years thereafter, the task force 
described in paragraph (1) shall develop and submit 
to the Committee on Health, Education, Labor, and 
Pensions and the Committee on Appropriations of 
the Senate and the Committee on Energy and Com-
merce and the Committee on Appropriations of the 
House of Representatives a plan regarding Federal 
programs and activities to combat antimicrobial re-
sistance, including measurable outcomes, as appro-
priate, informed by— 
‘‘(A) the agenda described in paragraph 
(3); 
‘‘(B) input provided by the Advisory Coun-
cil described in subsection (b); and 
‘‘(C) input from other relevant stake-
holders provided pursuant to paragraph (2).’’; 
(2) by redesignating subsections (b) through (o) 
as subsections (c) through (p), respectively; 
(3) by inserting after subsection (a) the fol-
lowing: 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00450
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
451 
‘‘(b) ADVISORY COUNCIL.— 
‘‘(1) IN
GENERAL.—The Secretary may con-
tinue the Presidential Advisory Council on Com-
bating Antibiotic-Resistant Bacteria, referred to in 
this subsection as the ‘Advisory Council’. 
‘‘(2) DUTIES.—The Advisory Council shall ad-
vise and provide information and recommendations 
to the Secretary, acting through the Task Force es-
tablished under subsection (a), regarding Federal 
programs and activities intended to reduce or com-
bat antimicrobial-resistant bacteria or fungi that 
may present a public health threat and improve ca-
pabilities to prevent, diagnose, mitigate, or treat 
such resistance. Such advice, information, and rec-
ommendations may be related to improving Federal 
efforts related to factors described in subsection 
(a)(3) and other topics related to antimicrobial re-
sistance, as appropriate. 
‘‘(3) MEETINGS AND COORDINATION.— 
‘‘(A) MEETINGS.—The Advisory Council 
shall meet not less frequently than biannually 
and, to the extent practicable, in coordination 
with meetings of the task force established 
under subsection (a). 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00451
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
452 
‘‘(B) 
COORDINATION.—The 
Advisory 
Council shall, to the greatest extent practicable, 
coordinate activities carried out by the Council 
with the task force established under subsection 
(a). 
‘‘(4) FACA.—Chapter 10 of title 5, United 
States Code, shall apply to the activities and duties 
of the Advisory Council. 
‘‘(5) SUNSET.— 
‘‘(A) IN GENERAL.—The Advisory Council 
under this subsection shall terminate on De-
cember 31, 2026. 
‘‘(B) EXTENSION
OF
ADVISORY
COUN-
CIL.—Not later than October 1, 2026, the Sec-
retary shall submit to the Committee on 
Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Com-
merce of the House of Representatives a report 
that includes a recommendation on whether the 
Advisory Council should be extended, and iden-
tifying whether there are other committees, 
councils, or task forces that have overlapping or 
similar duties to that of the Advisory Council, 
and whether such committees, councils, or task 
forces should be combined, restructured, or 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00452
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
453 
eliminated, including with respect to the task 
force established under subsection (a).’’; and 
(4) in subsection (n), as so redesignated, by 
striking ‘‘(f) through (j)’’ and inserting ‘‘(g) through 
(k)’’. 
(b) CONFORMING AMENDMENT.—Section 505 of the 
Pandemic and All-Hazards Preparedness and Advancing 
Innovation Act of 2019 (42 U.S.C. 247d–5 note; Public 
Law 116–22) is amended by striking subsection (a) and 
all that follows through ‘‘Not later’’ in subsection (e) and 
inserting the following: 
‘‘Not later’’. 
SEC. 625. STRATEGIC NATIONAL STOCKPILE AND MATE-
RIAL THREATS. 
Section 319F–2 of the Public Health Service Act (42 
U.S.C. 247d–6b) is amended— 
(1) in subsection (a)— 
(A) in paragraph (2)— 
(i) in subparagraph (A), by inserting 
‘‘Such review shall include a description of 
how the Secretary manages and mitigates 
risks associated with gaps between current 
inventory levels and stockpiling goals, 
prioritizes such risks, and tracks progress 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00453
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
454 
toward mitigation of such risks.’’ after the 
first sentence; and 
(ii) in subparagraph (B)(i), by amend-
ing subclause (IV) to read as follows: 
‘‘(IV) the emergency health secu-
rity threat or threats such counter-
measure procurement is intended to 
address, including— 
‘‘(aa) whether such procure-
ment is consistent with meeting 
emergency health security needs 
associated with such threat or 
threats; and 
‘‘(bb) in the case of a coun-
termeasure that addresses a bio-
logical agent, whether such agent 
has an increased likelihood to be-
come resistant to, more resistant 
to, 
or 
evade, 
such 
counter-
measure relative to other avail-
able medical countermeasures;’’; 
(B) in paragraph (3)— 
(i) in subparagraph (B), by striking 
‘‘are followed, regularly reviewed, and up-
dated with respect to such stockpile’’ and 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00454
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
455 
inserting ‘‘with respect to such stockpile 
are followed, regularly reviewed, and up-
dated to reflect best practices’’; 
(ii) in subparagraph (I), by inserting 
‘‘, through a standard operating proce-
dure,’’ after ‘‘ensure’’; 
(iii) by redesignating subparagraphs 
(H) through (K) as subparagraphs (I) 
through (L), respectively; 
(iv) by inserting after subparagraph 
(G) the following: 
‘‘(H) utilize tools to enable the timely and 
accurate tracking of the contents of the stock-
pile throughout the deployment of such con-
tents, including tracking of the location and ge-
ographic distribution and utilization of such 
contents;’’; 
(v) in subparagraph (K), as so redes-
ignated, by striking ‘‘; and’’ at the end and 
inserting a semicolon; 
(vi) in subparagraph (L), as so redes-
ignated, by striking the period and insert-
ing ‘‘; and’’; and 
(vii) by adding at the end the fol-
lowing: 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00455
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
456 
‘‘(M) communicate to relevant vendors re-
garding modifications, renewals, extensions, or 
terminations of contracts, or the intent to exer-
cise options for such contracts, within 30 days, 
as practicable, of such determination, including 
through the development of a contract notifica-
tion process.’’; 
(C) in paragraph (5)(B), in the matter 
preceding clause (i), by inserting ‘‘, which may 
accompany the review required under paragraph 
(2),’’ after ‘‘Representatives a report’’; and 
(D) in paragraph (6)(A)— 
(i) by redesignating clauses (viii) 
through (x) as clauses (ix) through (xi), re-
spectively; and 
(ii) by inserting after clause (vii) the 
following: 
‘‘(viii) with respect to any change in 
the Federal organizational management of 
the stockpile, an assessment and compari-
son of any differences in the processes and 
operations resulting from such change, in-
cluding— 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00456
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
457 
‘‘(I) planning for potential coun-
termeasure deployment, distribution, 
or dispensing capabilities; 
‘‘(II) organizational structure; 
‘‘(III) communication with rel-
evant stakeholders related to procure-
ment decisions; 
‘‘(IV) processes related to pro-
curement, deployment, and use of 
stockpiled countermeasures; 
‘‘(V) communication and coordi-
nation with the Public Health Emer-
gency Medical Countermeasures En-
terprise and other related Federal en-
tities; 
‘‘(VI) 
inventory 
management; 
and 
‘‘(VII) availability and use of re-
sources for such activities;’’; and 
(2) 
in 
subsection 
(c)(2)(C), 
by 
striking 
‘‘promptly’’ and inserting ‘‘, not later than 60 days 
after each such determination,’’; 
(3) 
in 
subsection 
(f)(1), 
by 
striking 
‘‘$610,000,000 for each of fiscal years 2019 through 
2021, and $750,000,000 for each of fiscal years 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00457
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
458 
2022 and 2023’’ and inserting ‘‘$1,100,000,000 for 
fiscal year 2025, and $1,210,000,000 for fiscal year 
2026’’; and 
(4) in subsection (g)(1), by striking ‘‘2019 
through 2028’’ and inserting ‘‘2025 through 2034’’. 
SEC. 
626. 
MEDICAL 
COUNTERMEASURES 
FOR 
VIRAL 
THREATS WITH PANDEMIC POTENTIAL. 
Section 319L of the Public Health Service Act (42 
U.S.C. 247d–7e) is amended— 
(1) in subsection (c)— 
(A) in paragraph (4)— 
(i) in subparagraph (D)— 
(I) in clause (ii), by striking ‘‘; 
and’’ and inserting a semicolon; 
(II) by redesignating clause (iii) 
as clause (iv); and 
(III) by inserting after clause (ii) 
the following: 
‘‘(iii) research and development of 
medical countermeasures for priority virus 
families that have significant potential to 
cause a pandemic, including such counter-
measures that take either pathogen-specific 
or pathogen-agnostic approaches, and plat-
form technologies to improve the develop-
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00458
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS
500 
tion and treatment of complications of sickle cell dis-
ease’’; 
(3) in paragraph (3)— 
(A) in subparagraph (A), by striking 
‘‘enter into a contract with’’ and inserting 
‘‘make a grant to, or enter into a contract or 
cooperative agreement with,’’; and 
(B) in subparagraph (B), in each of 
clauses (ii) and (iii), by striking ‘‘prevention 
and treatment of sickle cell disease’’ and insert-
ing ‘‘treatment of sickle cell disease and the 
prevention and treatment of complications of 
sickle cell disease’’; and 
(4) in paragraph (6), by striking ‘‘$4,455,000 
for each of fiscal years 2019 through 2023’’ and in-
serting ‘‘$8,205,000 for each of fiscal years 2025 
through 2029’’. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that further research should be undertaken to ex-
pand the understanding of the causes of, and to find cures 
for, heritable blood disorders, including sickle cell disease. 
SEC. 705. TRAUMATIC BRAIN INJURIES. 
(a) THE BILL PASCRELL, JR., NATIONAL PROGRAM 
FOR TRAUMATIC BRAIN INJURY SURVEILLANCE
AND 
REGISTRIES.— 
VerDate Sep 11 2014 
21:22 Jun 10, 2025
Jkt 059200
PO 00000
Frm 00500
Fmt 6652
Sfmt 6201
E:\BILLS\H1768.IH
H1768
ssavage on LAPJG3WLY3PROD with BILLS